Comments
Loading...

Johnson & Johnson Analyst Ratings

JNJNYSE
Logo brought to you by Benzinga Data
$155.23
0.200.13%
At close: -
$155.97
0.740.48%
After Hours: 4:14 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$215.00
Lowest Price Target1
$150.00
Consensus Price Target1
$170.00

Johnson & Johnson Analyst Ratings and Price Targets | NYSE:JNJ | Benzinga

Johnson & Johnson has a consensus price target of $170 based on the ratings of 19 analysts. The high is $215 issued by Cantor Fitzgerald on October 16, 2024. The low is $150 issued by Daiwa Capital on July 23, 2024. The 3 most-recent analyst ratings were released by RBC Capital, Leerink Partners, and Barclays on June 5, 2025, May 13, 2025, and April 17, 2025, respectively. With an average price target of $166.33 between RBC Capital, Leerink Partners, and Barclays, there's an implied 6.64% upside for Johnson & Johnson from these most-recent analyst ratings.

Analyst Trends and Forecast
1
1
Feb
3
Mar
6
5
Apr
1
May
1
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

RBC Capital
Leerink Partners
Barclays
Raymond James
Morgan Stanley

1calculated from analyst ratings

Analyst Ratings for Johnson & Johnson

Buy NowGet Alert
06/05/2025Buy Now16.05%RBC Capital
Shagun Singh57%
$181 → $181ReiteratesOutperform → OutperformGet Alert
05/13/2025Buy Now-1.9%Leerink Partners
David Risinger71%
$169 → $153DowngradeOutperform → Market PerformGet Alert
04/17/2025Buy Now5.79%Barclays
Matt Miksic67%
$166 → $165MaintainsEqual-WeightGet Alert
04/16/2025Buy Now5.15%Raymond James
Jayson Bedford68%
$162 → $164MaintainsOutperformGet Alert
04/16/2025Buy Now8.35%Morgan Stanley
Terence Flynn65%
$164 → $169MaintainsEqual-WeightGet Alert
04/16/2025Buy Now16.05%RBC Capital
Shagun Singh57%
$181 → $181ReiteratesOutperform → OutperformGet Alert
04/14/2025Buy Now3.87%Raymond James
Jayson Bedford68%
$165 → $162MaintainsOutperformGet Alert
04/10/2025Buy Now1.94%B of A Securities
Tim Anderson63%
$171 → $159MaintainsNeutralGet Alert
04/09/2025Buy Now5.15%Morgan Stanley
Terence Flynn65%
$163 → $164MaintainsEqual-WeightGet Alert
04/09/2025Buy Now10.28%Goldman Sachs
Asad Haider 57%
$157 → $172UpgradeNeutral → BuyGet Alert
04/03/2025Buy Now16.05%RBC Capital
Shagun Singh57%
$181 → $181ReiteratesOutperform → OutperformGet Alert
04/02/2025Buy Now16.05%RBC Capital
Shagun Singh57%
$181 → $181ReiteratesOutperform → OutperformGet Alert
04/02/2025Buy NowGuggenheim
Vamil Divan73%
ReiteratesNeutral → NeutralGet Alert
03/12/2025Buy NowGuggenheim
Vamil Divan73%
ReiteratesNeutral → NeutralGet Alert
03/10/2025Buy NowGuggenheim
Vamil Divan73%
ReiteratesNeutral → NeutralGet Alert
03/05/2025Buy Now9.64%B of A Securities
Tim Anderson63%
$159 → $171MaintainsNeutralGet Alert
02/19/2025Buy Now16.05%RBC Capital
Shagun Singh57%
$181 → $181ReiteratesOutperform → OutperformGet Alert
02/03/2025Buy Now6.43%Guggenheim
Vamil Divan73%
$162 → $166MaintainsNeutralGet Alert
01/28/2025Buy Now6.43%Barclays
Matt Miksic67%
$159 → $166MaintainsEqual-WeightGet Alert
01/23/2025Buy Now16.05%RBC Capital
Shagun Singh57%
$181 → $181ReiteratesOutperform → OutperformGet Alert
01/23/2025Buy Now4.51%Morgan Stanley
Terence Flynn65%
$175 → $163MaintainsEqual-WeightGet Alert
01/23/2025Buy Now-0.62%Stifel
Rick Wise74%
$170 → $155MaintainsHoldGet Alert
01/23/2025Buy Now8.35%Leerink Partners
David Risinger71%
$182 → $169MaintainsOutperformGet Alert
01/23/2025Buy Now-2.55%Wells Fargo
Larry Biegelsen66%
$166 → $152MaintainsEqual-WeightGet Alert
01/23/2025Buy Now5.79%Raymond James
Jayson Bedford68%
$170 → $165MaintainsOutperformGet Alert
01/23/2025Buy Now1.94%B of A Securities
Tim Anderson63%
$160 → $159MaintainsNeutralGet Alert
01/17/2025Buy Now2.58%B of A Securities
Tim Anderson63%
$166 → $160MaintainsNeutralGet Alert
12/11/2024Buy Now12.2%Citigroup
Joanne Wuensch75%
$185 → $175MaintainsBuyGet Alert
12/10/2024Buy Now6.43%B of A Securities
Tim Anderson63%
→ $166Reinstates → NeutralGet Alert
11/15/2024Buy Now21.82%Wolfe Research
Alexandria Hammond48%
→ $190Initiates → OutperformGet Alert
11/06/2024Buy Now3.87%Guggenheim
Vamil Divan73%
$156 → $162MaintainsNeutralGet Alert
10/16/2024Buy Now18.61%Citigroup
Joanne Wuensch75%
$180 → $185MaintainsBuyGet Alert
10/16/2024Buy Now6.43%Wells Fargo
Larry Biegelsen66%
$163 → $166MaintainsEqual-WeightGet Alert
10/16/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
10/16/2024Buy Now16.05%RBC Capital
Shagun Singh57%
$178 → $181MaintainsOutperformGet Alert
10/16/2024Buy Now12.2%Morgan Stanley
Terence Flynn65%
$169 → $175MaintainsEqual-WeightGet Alert
10/10/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
10/08/2024Buy Now14.12%RBC Capital
Shagun Singh57%
$175 → $178MaintainsOutperformGet Alert
09/30/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
09/23/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
09/20/2024Buy Now12.2%RBC Capital
Shagun Singh57%
$175 → $175ReiteratesOutperform → OutperformGet Alert
09/19/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
09/16/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
09/09/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
09/03/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
08/05/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
07/30/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
07/30/2024Buy Now12.2%RBC Capital
Shagun Singh57%
$175 → $175ReiteratesOutperform → OutperformGet Alert
07/23/2024Buy Now-3.83%Daiwa Capital
Narumi Nakagiri22%
$160 → $150DowngradeOutperform → NeutralGet Alert
07/19/2024Buy Now-0.62%Goldman Sachs
Chris Shibutani56%
$160 → $155MaintainsNeutralGet Alert
07/18/2024Buy Now12.2%RBC Capital
Shagun Singh57%
$175 → $175ReiteratesOutperform → OutperformGet Alert
07/18/2024Buy Now18.61%TD Cowen
Joshua Jennings57%
$195 → $185MaintainsBuyGet Alert
07/18/2024Buy Now8.35%Morgan Stanley
Terence Flynn65%
$167 → $169MaintainsEqual-WeightGet Alert
07/01/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
06/25/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
06/20/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
06/17/2024Buy Now12.2%RBC Capital
Shagun Singh57%
$175 → $175ReiteratesOutperform → OutperformGet Alert
06/04/2024Buy Now12.2%RBC Capital
Shagun Singh57%
$175 → $175ReiteratesOutperform → OutperformGet Alert
05/22/2024Buy Now12.2%RBC Capital
Shagun Singh57%
$175 → $175ReiteratesOutperform → OutperformGet Alert
05/16/2024Buy Now12.2%RBC Capital
Shagun Singh57%
$175 → $175ReiteratesOutperform → OutperformGet Alert
05/06/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
04/18/2024Buy Now9%HSBC
Morten Herholdt30%
$169 → $170UpgradeHold → BuyGet Alert
04/17/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
04/17/2024Buy Now7.07%Morgan Stanley
Terence Flynn65%
$168 → $167MaintainsEqual-WeightGet Alert
04/17/2024Buy Now12.2%RBC Capital
Shagun Singh57%
$181 → $175MaintainsOutperformGet Alert
04/17/2024Buy Now9%B of A Securities
Geoff Meacham62%
$180 → $170MaintainsNeutralGet Alert
04/15/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
03/13/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
02/28/2024Buy Now16.05%RBC Capital
Shagun Singh57%
$181 → $181ReiteratesOutperform → OutperformGet Alert
02/20/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
02/06/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
01/24/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
01/24/2024Buy Now16.05%RBC Capital
Shagun Singh57%
$181 → $181ReiteratesOutperform → OutperformGet Alert
01/24/2024Buy Now8.35%Morgan Stanley
Terence Flynn65%
$170 → $169MaintainsEqual-WeightGet Alert
01/23/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
→ $215ReiteratesOverweight → OverweightGet Alert
01/09/2024Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
01/03/2024Buy Now12.2%Raymond James
Jayson Bedford68%
$172 → $175MaintainsOutperformGet Alert
12/13/2023Buy Now4.51%Wells Fargo
Larry Biegelsen66%
$170 → $163DowngradeOverweight → Equal-WeightGet Alert
12/06/2023Buy Now16.05%RBC Capital
Shagun Singh57%
$178 → $181MaintainsOutperformGet Alert
12/01/2023Buy Now14.12%RBC Capital
Shagun Singh57%
$178 → $178ReiteratesOutperform → OutperformGet Alert
12/01/2023Buy Now15.41%UBS
Danielle Antalffy61%
→ $180UpgradeNeutral → BuyGet Alert
11/20/2023Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
→ $215ReiteratesOverweight → OverweightGet Alert
11/17/2023Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
→ $215ReiteratesOverweight → OverweightGet Alert
10/23/2023Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
10/18/2023Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
10/18/2023Buy Now10.28%Raymond James
Jayson Bedford68%
$179 → $172MaintainsOutperformGet Alert
10/18/2023Buy Now9.64%Morgan Stanley
Terence Flynn65%
$174 → $171MaintainsEqual-WeightGet Alert
10/12/2023Buy Now3.87%Barclays
Matt Miksic67%
$158 → $162MaintainsEqual-WeightGet Alert
10/11/2023Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
$215 → $215ReiteratesOverweight → OverweightGet Alert
10/11/2023Buy Now11.56%Morgan Stanley
Terence Flynn65%
$172 → $174MaintainsEqual-WeightGet Alert
10/09/2023Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
→ $215ReiteratesOverweight → OverweightGet Alert
10/05/2023Buy Now14.12%RBC Capital
Shagun Singh57%
→ $178Initiates → OutperformGet Alert
10/02/2023Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
→ $215ReiteratesOverweight → OverweightGet Alert
09/18/2023Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
→ $215ReiteratesOverweight → OverweightGet Alert
09/08/2023Buy Now1.3%Barclays
Matt Miksic67%
$175 → $158MaintainsEqual-WeightGet Alert
09/06/2023Buy Now12.2%HSBC
Morten Herholdt30%
→ $175Initiates → HoldGet Alert
09/05/2023Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
→ $215ReiteratesOverweight → OverweightGet Alert
09/05/2023Buy Now14.77%Raymond James
Jayson Bedford68%
$184 → $179MaintainsOutperformGet Alert
08/31/2023Buy Now19.25%Wells Fargo
Larry Biegelsen66%
$195 → $186MaintainsOverweightGet Alert
08/31/2023Buy Now37.85%Cantor Fitzgerald
Louise Chen57%
→ $215ReiteratesOverweight → OverweightGet Alert

FAQ

Q

What is the target price for Johnson & Johnson (JNJ) stock?

A

The latest price target for Johnson & Johnson (NYSE:JNJ) was reported by RBC Capital on June 5, 2025. The analyst firm set a price target for $181.00 expecting JNJ to rise to within 12 months (a possible 16.05% upside). 57 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Johnson & Johnson (JNJ)?

A

The latest analyst rating for Johnson & Johnson (NYSE:JNJ) was provided by RBC Capital, and Johnson & Johnson reiterated their outperform rating.

Q

When was the last upgrade for Johnson & Johnson (JNJ)?

A

The last upgrade for Johnson & Johnson happened on April 9, 2025 when Goldman Sachs raised their price target to $172. Goldman Sachs previously had a neutral for Johnson & Johnson.

Q

When was the last downgrade for Johnson & Johnson (JNJ)?

A

The last downgrade for Johnson & Johnson happened on May 13, 2025 when Leerink Partners changed their price target from $169 to $153 for Johnson & Johnson.

Q

When is the next analyst rating going to be posted or updated for Johnson & Johnson (JNJ)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Johnson & Johnson, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Johnson & Johnson was filed on June 5, 2025 so you should expect the next rating to be made available sometime around June 5, 2026.

Q

Is the Analyst Rating Johnson & Johnson (JNJ) correct?

A

While ratings are subjective and will change, the latest Johnson & Johnson (JNJ) rating was a reiterated with a price target of $181.00 to $181.00. The current price Johnson & Johnson (JNJ) is trading at is $155.97, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch